Renal Complications after Hematopoietic Stem Cell Transplantation: Role of Graft-Versus-Host Disease in Renal Thrombotic Microangiopathy

Clicks: 318
ID: 119416
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Hematopoietic stem cell transplantation (HSCT) is a widely accepted treatment for mainly hematopoietic disorders. Recent advances in transplantation techniques have increased the number of long-time survivors with chronic kidney disease (CKD). The presence of CKD affects outcomes and is associated w …
Reference Key
a2020journalrenal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mii A;Shimizu A;Yamaguchi H;Tsuruoka S;;
Journal journal of nippon medical school = nippon ika daigaku zasshi
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/31776318/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine renal insufficiency immunosuppressive agents / therapeutic use hematopoietic stem cell transplantation* postoperative complications / etiology* chronic / etiology* pmid:31776318 doi:10.1272/jnms.jnms.2020_87-102 akiko mii akira shimizu shuichi tsuruoka graft vs host disease / drug therapy graft vs host disease / etiology* thrombotic microangiopathies / drug therapy thrombotic microangiopathies / etiology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.